HomePolicy

Policy

Jamaica Paper - Latest News and In-depth Analysis
Policy

Argent BioPharma: A Hidden Gem traded Under $12M--Edison Group Report Assigned a $327M Valuation to Its Breakthrough Epilepsy Treatment

PERTH,Australia,Feb. 6,2025-- Argent BioPharma (ASX: RGT) (OTCQB: RGTLF),a clinical-stage biopharmaceutical company brings hope to epilepsy patients.

Feb 7, 2025
Policy

GCCL Applauded by Frost & Sullivan for Ensuring Consistent, Reliable Clinical Trial Data in APAC

GCCL is committed to customer success,emphasizing quality control at every stage—from analysis consulting and sample processing to data management—ensuring efficient clinical trials and research an

Feb 7, 2025
Policy

TCL CSOT Showcases Cutting-edge Professional Display Solutions at ISE 2025

BARCELONA,Spain,Feb. 6,2025-- TCL CSOT,a global leader in display technology,is set to present its latest professional display innovations at Integrated Systems Europe (ISE) 2025,taking place from Feb

Feb 7, 2025
Policy

NetEase to Report Fourth Quarter and Fiscal Year 2024 Financial Results on February 20

HANGZHOU,China,Feb. 6,2025-- NetEase,Inc. (NASDAQ: NTES and HKEX: 9999,"NetEase" or the "Company"),a leading internet and game services provider,today announced that it will report

Feb 7, 2025
Policy

Anti-HER2 Bispecific ADC JSKN003 Received Approval to Initiate a Phase III Clinical Study for the Treatment of HER2-positive Breast Cancer

SUZHOU,China,Feb. 6,2025-- Alphamab Oncology (Stock Code: 9966.HK) and CSPC Pharmaceutical Group Co.,Ltd. ("CSPC") (Stock Code: 1093.HK) jointly announced that anti-HER2 biparatopic antibody

Feb 7, 2025
Policy

Personetics' New Features Give Banks More Ways to Monetize Customer Wellness

Personetics\' latest product release empowers financial institutions to develop highly personalized customer experiences that democratize financial advice,inspire action,and drive business value

Feb 7, 2025
1 ... 64 65 66 67 68 69 70 ... 98